Non-Invasive Prenatal Testing (NIPT) for (Down, Edwards & Patau Syndrome) & Early Gender Testing in Stanmore and Surrounding Areas

At Niva Medical Clinic, based in Stanmore and serving Harrow, Edgware, Bushey, and surrounding areas, we are proud to offer Non-Invasive Prenatal Testing (NIPT) and early gender testing as part of our comprehensive pregnancy care services.

Whether you’re seeking reassurance about your baby’s health or eager to learn your baby’s gender early, we are here to support you throughout your pregnancy journey.

What is NIPT?

NIPT (Non-Invasive Prenatal Testing) is a safe, highly accurate screening test that uses a simple maternal blood sample to analyse cell-free fetal DNA (cfDNA) circulating in the mother’s bloodstream. It is typically performed from 10 weeks of pregnancy onwards.

NIPT screens for common chromosomal conditions, including:

Trisomy 21 (Down syndrome)
Trisomy 18 (Edwards syndrome)
Trisomy 13 (Patau syndrome)
Sex chromosome aneuploidies, such as:

  • X (0)Turner syndrome
  • XXYKlinefelter syndrome
  • XYYJacob’s syndrome
  • XXXTriple X syndrome

The test requires a simple venous blood draw from the mother’s arm, with no risk to the baby. Results are typically available within 5-7 working days.

NIPT Accuracy

Compared to traditional NHS combined first trimester screening, NIPT offers higher accuracy and a lower false-positive rate.

Test Type Sensitivity (Detection Rate) False Positive Rate
Combined First Trimester Screening ~82% 1 in 26
NIPT >99% <1 in 1,000

 

NIPT Sensitivity & Specificity

Condition Sensitivity (Detection) Specificity
Trisomy 21 >99.9% (95% CI: 97.1%) >99.90% (95% CI: 99.63%)
Trisomy 18 >99.9% (95% CI: 91.4%) >99.90% (95% CI: 97.1%)
Trisomy 13 >99.9% (95% CI: 87.1%) >99.90% (95% CI: 99.64%)

 

Limitations of NIPT

While NIPT is a highly accurate screening tool, it has certain limitations. It is not suitable for patients with:

Recent maternal blood transfusion
Maternal mosaicism
Maternal prior organ or stem cell transplant
Maternal copy number variations
Maternal autoimmune disease
Maternal neoplasms (benign or malignant)
Fetoplacental mosaicism or confined placental mosaicism
Fetal demise or vanishing twin syndrome

Other important limitations:

🔸 Sex chromosome anomalies cannot be reported in twin pregnancies.
🔸 NIPT is not validated for pregnancies with:

  • More than two fetuses
  • Partial chromosomal aneuploidy
  • Triploidy
  • Translocations
  • Maternal aneuploidy
  • Transplants
  • Malignancies

🔸 NIPT does not detect neural tube defects.
🔸 In twin pregnancies:

  • A high-probability result applies to at least one fetus.
  • A male result applies to one or both fetuses.
  • A female result applies to both fetuses.

Early Gender Testing from 6 Weeks

We also offer early gender testing from 6 weeks of pregnancy using a simple maternal blood test. This test provides highly accurate gender results (99.9% accuracy), allowing you to prepare and bond with your baby earlier in your pregnancy.

Why Choose Niva Medical Clinic, Stanmore?

Local and convenient – easily accessible from Stanmore, Harrow, Edgware, Bushey, Watford, and surrounding areas
Quick results – NIPT and gender test results within 5-7 working days
Simple, safe testing – just a maternal blood sample required
Personalised, expert care – from experienced GPs and pregnancy specialists
Flexible appointments – including evenings and weekends

Book Your NIPT or Gender Test in Stanmore Today

Gain peace of mind with early, accurate insights into your baby’s health and gender. If you’re based in Stanmore, Harrow, Edgware, Hatch End, Pinner or nearby, contact Niva Medical Clinic today to book your NIPT or early gender testing appointment.

📞 Call us today on 020 8865 1938 or enquire via our website/chat/email to schedule your appointment.

Important Note

NIPT is a screening test, not diagnostic. High-probability results should be confirmed through diagnostic testing (such as amniocentesis or chorionic villus sampling). Early gender testing is highly accurate but should be confirmed at the routine 20-week anomaly scan.

Share this:

Facebook
Twitter
LinkedIn

Recent Posts

Many men begin to notice subtle but persistent changes after the age of 40. Energy levels dip, muscle becomes harder to maintain, recovery slows, mood can flatten, and sexual function may not feel as reliable as it once did. While these changes are often dismissed as “normal ageing”, the reality is more nuanced. Hormonal shifts, particularly in testosterone, interact closely with cardiovascular health, metabolism, mental wellbeing and erectile function.

Injectable weight-loss medications such as Ozempic, Wegovy and Mounjaro have changed the conversation around obesity and type 2 diabetes. For some people, they offer long-term metabolic improvements that were previously difficult to achieve. For others, concerns around safety, side effects and long-term use remain a barrier.

The UK health insurance market has seen significant growth in recent years, valued at £6-7 billion in gross premiums for 2023-2024. As NHS waiting lists continue to rise, reaching over 7 million, more individuals are turning to private healthcare options for faster and more accessible treatment